Ad is loading...
DEMGX
Price
$11.47
Change
-$0.03 (-0.26%)
Updated
Nov 15 closing price
RNWFX
Price
$80.56
Change
-$0.79 (-0.97%)
Updated
Nov 15 closing price
Ad is loading...

DEMGX vs RNWFX

Header iconDEMGX vs RNWFX Comparison
Open Charts DEMGX vs RNWFXBanner chart's image
DFA Emerging Markets Trgt Val Instl
Price$11.47
Change-$0.03 (-0.26%)
VolumeN/A
CapitalizationN/A
American Funds New World R5
Price$80.56
Change-$0.79 (-0.97%)
VolumeN/A
CapitalizationN/A
DEMGX vs RNWFX Comparison Chart
Loading...
View a ticker or compare two or three
VS
DEMGX vs. RNWFX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DEMGX is a Sell and RNWFX is a Buy.

FUNDAMENTALS
Fundamentals
RNWFX has more cash in the bank: 60.9B vs. DEMGX (257M). DEMGX pays higher dividends than RNWFX: DEMGX (3.47) vs RNWFX (1.51). DEMGX was incepted earlier than RNWFX: DEMGX (6 years) vs RNWFX (23 years). RNWFX is a more actively managed with annual turnover of: 32.00 vs. DEMGX (24.00). DEMGX has a lower initial minimum investment than RNWFX: DEMGX (0) vs RNWFX (250). RNWFX annual gain was more profitable for investors over the last year : 11.54 vs. DEMGX (8.79). DEMGX return over 5 years is better than : 21.96 vs. RNWFX (17.17).
DEMGXRNWFXDEMGX / RNWFX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence6 years23 years-
Gain YTD4.6537.09966%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets257M60.9B0%
Annual Yield % from dividends3.471.51231%
Returns for 1 year8.7911.5476%
Returns for 3 years-6.50-14.5545%
Returns for 5 years21.9617.17128%
Returns for 10 yearsN/A41.00-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VRNA35.660.29
+0.82%
Verona Pharma plc
BURL268.94-0.65
-0.24%
Burlington Stores
RCMT22.25-0.38
-1.68%
RCM Technologies
SNTI2.15-0.18
-7.73%
Senti Biosciences Inc.
CATX7.88-1.04
-11.66%
Perspective Therapeutics